pentobarbital will lessen the extent or outcome of nilotinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
Watch Carefully (1)pentobarbital will improve the amount or outcome of clopidogrel by impacting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will decrease the extent or result of parecoxib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Unfamiliar.
pentobarbital will lower the level or influence of irinotecan liposomal by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check.
Medication that have quantity limits connected to Every prescription. This restriction normally limitations the quantity from the drug that can be included.
pentobarbital will decrease the extent or result of zolpidem by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Small/Significance Unidentified.
pentobarbital will decrease the extent or effect of cariprazine by influencing hepatic/intestinal enzyme CYP3A4 metabolism.
Watch Carefully (3)pentobarbital will decrease the extent or influence of diazepam intranasal by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch. Solid or reasonable CYP3A4 inducers could improve level of diazepam elimination; hence, efficacy of diazepam can be diminished.
fentanyl transdermal and pentobarbital the two raise sedation. Stay away from or Use Alternate Drug. Limit use to patients for whom alternate procedure possibilities are inadequate
pentobarbital will minimize the extent or result of fentanyl by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep an eye on Intently. Coadministration of fentanyl with CYP3A4 inducers could lead to the reduce in fentanyl plasma concentrations, lack of efficacy or, maybe, advancement of the withdrawal syndrome in a very individual who has produced Actual physical dependence to fentanyl.
pentobarbital will lower the extent or effect of ramelteon by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Small/Importance Unknown.
Contraindicated (one)pentobarbital will reduce the extent or result of lumefantrine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration with strong CYP3A4 inducers can result in diminished serum concentrations and lack of antimalarial efficacy
pentobarbital will lower the level or effect of dasatinib by affecting hepatic/intestinal enzyme check here CYP3A4 metabolism. Use Warning/Monitor.
pentobarbital will minimize the extent or influence of levamlodipine by impacting hepatic/intestinal enzyme CYP3A4 metabolism.